Canine PD-L1
Overview:
Canine PD-L1 is an antibody immunotherapy that has been tested in a syngeneic bladder cancer mouse model.
Status:
Purdue Faculty:
Quick Links
Canine PD-L1 is an antibody immunotherapy that has been tested in a syngeneic bladder cancer mouse model.
Purdue University, 610 Purdue Mall, West Lafayette, IN 47907, (765) 494-4600
© 2024 Purdue University | An equal access/equal opportunity university | Copyright Complaints | Maintained by the Office of the Executive Vice President for Research and Partnerships
Trouble with this page? Disability-related accessibility issue? Please contact EVPRP at vprweb@purdue.edu.